Low cytoplasmic NUB1 protein exerts hypoxic cell death with poorer prognosis in oestrogen receptor negative breast cancer patients

Current prognostic biomarkers fall short in stratifying Oestrogen receptor (ER)-negative breast cancer patients regarding tumour progression risk at diagnosis. The role of AIPL1 in activating its tumour suppressor client protein, NEDD8 Ultimate Buster-1 (NUB1) remains unknown in cancer. Our study de...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Ka-Liong Tan, Syed Haider, Christos E. Zois, Jianting Hu, Helen Turley, Russell Leek, Francesca Buffa, Oreste Acuto, Adrian L. Harris, Francesco Pezzella
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Elsevier 2024-11-01
Colecção:	Translational Oncology
Assuntos:	NUB1 Oestrogen receptor Immunohistochemistry Biomarkers
Acesso em linha:	http://www.sciencedirect.com/science/article/pii/S193652332400233X
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!